SCHEMBL943316

SCHEMBL943316

CC1=NC(c2cccc(Br)c2)(C(C)C)NC1=S

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.34
HSD17B10 Q99714 3/20 0.34
APOBEC3G Q9HC16 2/20 0.34
ALOX15 P16050 2/20 0.33
MAPK1 P28482 2/20 0.33
KDM4E B2RXH2 2/20 0.33
NPC1 O15118 1/20 0.33
TSHR P16473 1/20 0.33
CHRNA1 P02708 1/20 0.33
CHRNG P07510 1/20 0.33
CHRNB1 P11230 1/20 0.33
CHRNB2 P17787 1/20 0.33
SLC6A2 P23975 1/20 0.33
CHRNB4 P30926 1/20 0.33
SLC6A4 P31645 1/20 0.33
CHRNA3 P32297 1/20 0.33
CHRNA4 P43681 1/20 0.33
SLC6A3 Q01959 1/20 0.33
CHRND Q07001 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL944396 0.73 NCOA1 (0.33) ALDH1A1HSD17B10APOBEC3GALOX15MAPK1
SCHEMBL945249 0.73 CHRNA1 (0.37) ALDH1A1HSD17B10APOBEC3GMAPK1CHRNA1
SCHEMBL945466 0.71 CHRNA1 (0.36) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL947083 0.69 BACE1 (0.36) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2
SCHEMBL932469 0.69 BACE1 (0.31) BACE1
SCHEMBL6920536 0.69 BACE1 (0.39) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL946379 0.68
SCHEMBL945407 0.68 CYP3A4 (0.36) ALDH1A1KDM4EGAAMEN1KMT2A
SCHEMBL944383 0.67
SCHEMBL1082670 0.66 CHRNA1 (0.34) CHRNA1CHRNGCHRNB1CHRNB2SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed